Inventor · disambiguated record
Jérôme Courcambeck
Also filed as: COURCAMBECK JEROME · COURCAMBECK JÉRÔME
5 granted patents·2 pending applications·2 citations·filing 2003–2024
61Inventor score
Top patents by PatentIndex Score
7 records- 0157US2025074885A1Crystalline freebase form of 2-(4-chlorobenzylamino)-4-(4-tert-butylaminopiperidin-1-yl)-quinoline and uses thereofGENOSCIENCE PHARMA·Filed 2024·Application pending·0 cites
- 0256US10179770B2Quinolines derivatives as novel anticancer agentsGENOSCIENCE PHARMA·Filed 2014·Granted Jan 15, 2019·1 cites·29 claims
- 0356US8729014B2Specific HCV NS3 protease inhibitorsCOURCAMBECK JEROME·Filed 2011·Granted May 20, 2014·1 cites·20 claims
- 0445US2006142204A1Pyrrolidine derivatives for use in treating heaptitis c virus infectionGENOSCIENCE·Filed 2003·Application pending·0 cites
- 0534US11261189B2Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseasesGENOSCIENCE PHARMA·Filed 2019·Granted Mar 1, 2022·0 cites·36 claims
- 0630US10577362B2Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseasesGENOSCIENCE PHARMA·Filed 2017·Granted Mar 3, 2020·0 cites·31 claims
- 0723US10722505B2Substituted 2,4 diamino-quinoline as new anticancer agentsGENOSCIENCE PHARMA·Filed 2015·Granted Jul 28, 2020·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Jérôme Courcambeck files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →